| 贾晓妮,叶根洋,陈建波,等.药品集中带量采购政策实施后某医院抗精神病药物的使用情况分析[J].安徽医药,2023,27(9):1890-1895. |
| 药品集中带量采购政策实施后某医院抗精神病药物的使用情况分析 |
| Analysis of the use of antipsychotics in a hospital after the implementation of the centralized bulk-buying policy for drugs |
| |
| DOI：10.3969/j.issn.1009-6469.2023.09.044 |
| 中文关键词: 集体采购 抗精神病药 费用，药物 带量采购政策 用药情况 |
| 英文关键词: Group purchasing Antipsychotic agents Fees, pharmaceutical Bulk-buying policy Medication utilization |
| 基金项目:陕西省自然科学基础研究计划项目( 2022JQ-861)；西安市科技计划项目( 21YXYJ0077，21YXYJ0078) |
|
| 摘要点击次数: 1389 |
| 全文下载次数: 623 |
| 中文摘要: |
| 目的探讨药品集中带量采购政策实施后，在西安市某医院的实施效果以及对该院抗精神病药物使用情况的影响。方法收集西安市精神卫生中心医院信息系统(HIS)中带量采购执行前( 2018年 3月 25日至 2019年 3月 24日)带量采购执行后(2019年 3月 25日至 2020年 3月 24日、 2020年 3月 25日至 2021年 3月 24日)销量排名前十的抗精神病药物的用、量及销售金额，并按照世界卫生组织官网提供的药物限定日剂量( DDD)值，分别计算各药品在上述 3个时间段内的用药频度( DDDs)、日均费用( DDC)从而分析药品集中带量采购政策的实施对该院抗精神病药物使用情况的影响。结果该院的抗精神病药物主要有 18个品种、 39个品规，该研究收集销量排名前十的品种，包含 25个品规。其中奥氮平片(欧兰宁)及利培酮(索乐)降价幅度、 DDDs变化均较大，降价幅度分别为 58.22%、29.41%；对于 DDDs，奥氮平(欧兰宁)降低了 44.35%，利培酮片(索乐)降低 |
| 英文摘要: |
| Objective To explore the implementation effect of a centralized drug bulk-buying policy at a hospital in Xi'an and its impact on the use of antipsychotics in the hospital.Methods To collect the consumption and sales amount of the top ten antipsychot-ics in the Hospital Information System (HIS) of Xi'an Mental Health Center before the implementation of bulk-buying (March 25, 2018 -March 24, 2019) and after the implementation of bulk-buying (March 25, 2019 -March 24, 2020, March 25, 2020 -March 24, 2021).According to the drug defined daily dose (DDD) values provided by the official website of the World Health Organization, the frequency(DDDs) and average daily cost (DDC) of each drug were calculated in the above three time periods to analyze the impact of the imple-mentation of the centralized drug bulk-buying policy of medicines on the use of antipsychotics in the hospital.Results There were mainly 18 varieties and 39 grades of antipsychotics in the hospital, and the study collected the top 10 varieties in terms of sales volume,containing 25 grades. Among them, olanzapine tablets (Oulanning) and risperidone (Suole) had greater price reductions and changes inDDDs, with price reductions of 58.22% and 29.41%, respectively; for DDDs, olanzapine tablets (Oulanning) were reduced by 44.35%,and risperidone (Suole) was reduced by 9.74%; as for DDC, the DDC of the shortlisted bulk-buying products gradually decreased,among which the changes of olanzapine tablets (Oulanning) and risperidone tablets (Suole) were the most obvious, and the DDC of olan-zapine tablets (Oulanning) were RMB 15.05 yuan, RMB 9.63 yuan, and RMB 6.23 yuan before the implementation of bulk-buying and in one year and two years after the implementation of bulk-buying, and the DDC of risperidone tablets (Suole) was 0.84 yuan, 0.53 yuan,and 0.53 yuan, respectively, in one year and two years after bulk-buying.Conclusions The change range of DDDs and DDC of drugs has gradually developed in the direction of vector-price linkage, but there are still some drugs that do not yet reflect a linear relation- ship. The implementation of the drug bulk-buying policy has achieved certain results, and the drug cost of most patients has graduallydecreased, but there are still some issues that need to be improved. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
